Compare CRNX & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | MNTSW |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | 123 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | N/A |
| IPO Year | 2018 | 2019 |
| Metric | CRNX | MNTSW |
|---|---|---|
| Price | $47.42 | $0.02 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $71.00 | N/A |
| AVG Volume (30 Days) | ★ 992.2K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,535,000.00 | N/A |
| Revenue This Year | $425.41 | N/A |
| Revenue Next Year | $943.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.74 | N/A |
| 52 Week Low | $24.10 | N/A |
| 52 Week High | $54.18 | N/A |
| Indicator | CRNX | MNTSW |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 45.19 |
| Support Level | $43.04 | $0.02 |
| Resistance Level | $49.61 | $0.03 |
| Average True Range (ATR) | 1.94 | 0.01 |
| MACD | -0.24 | -0.00 |
| Stochastic Oscillator | 55.10 | 10.62 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.